Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EO9 Phase I intravesical study in non-muscle invasive bladder cancer
jRCT2080221248Phase 1
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of E09 in bladder cancer, sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
E09
03
Conditions
bladder cancer
Beyond the preview
Go deeper on jRCT2080221248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221248.